Abstract：Objective: To explore the value of SiLiankang in the treatment of myocardial damage in children with rotavirus diarrhea, and to summarize the clinical experience. Methods: 74 children with rotavirus diarrhea diagnosed and treated in our department from September 2018 to March 2019 were divided into control group (37 cases) and observation group (37 cases). The control group was treated with routine treatment. The observation group was treated with SiLiankang on the basis of routine diagnosis and treatment. The duration of persistent diarrhea, the level of GAS, MOT, VIP in serum and the therapeutic effect of the two groups were recorded and analyzed before and after treatment. Results: After 7 days of treatment, the duration of persistent diarrhea in the observation group (3.69 ±0.98d) was lower than that in the control group (4.40 ±1.04 d) (P<0.05). There was no significant difference in serum hormone indexes among the three groups before treatment. The level of GAS (725.45 ±123.74 μ g), MOT (266.41 ±58.47 μ g), VIP (144.28 ±40.19 μ g) in the observation group was lower than that in the control group before treatment, and there was no statistics between the observation group and the control group (P<0.05). The duration of persistent diarrhea in the two groups decreased after 4 days of treatment and 7 days after treatment, and the duration of persistent diarrhea in the observation group (3.69 ±0.98d) was lower than that in the control group (4.40 ±1.04d), and the duration of persistent diarrhea in the observation group (3.69 ±0.98d) was lower than that in the control group (4.40 ±1.04d), and the duration of persistent diarrhea in the observation group (3.69 ±0.98d) was lower than that in the control group. After treatment, the total effective treatment rate in the observation group (94.59%) was significantly higher than that in the control group (75.68%) (P<0.05). Conclusion: Siliankang plays an important role in the treatment of rotavirus diarrhea. It can obviously reduce the pathogenic hormones and inflammatory factors in children's body, and speed up the routine treatment. It is worth popularizing in related clinical diseases.
[1] 张玉凤,万涵,符佳,等.CK-MB、cTnI及BNP检测对小儿轮状病毒性肠炎心肌损害的临床意义[J].中国临床医生杂志,2018,46(10):1233~1235. [2] 吴倩,吴起武,张海龙,等.轮状病毒肠炎患儿395例肝功能及心肌酶谱分析[J].中国基层医药,2018,25(2):193~196. [3] 王芳,章青,李丹地,等.2017年兰州市5岁以下儿童轮状病毒腹泻流行特点分析[J].中华实验和临床病毒学杂志,2019,33(1):49~53. [4] Hera Nirwati, Celeste M. Donato, Yuli Mawarti, et al.Norovirus and rotavirus infections in children less than five years of age hospitalized with acute gastroenteritis in Indonesia [J].Archives of Virology, 2019,164 (6), pp.1515~1525. [5] Michael Haber,Benjamin A, Lopman,et al. Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design[J]. Vaccine,2019,37(24).3229~3233. [6] 陈幸.槐杞黄颗粒联合利巴韦林、亿活治疗轮状病毒感染性腹泻并心肌损害的临床价值[J].世界华人消化杂志,2018,595(11):60~65. [7] 高治华,刘菲.双歧杆菌四联活菌片和布拉酵母菌对轮状病毒性腹泻患儿的治疗效果及对心肌酶的影响[J].山西医药杂志,2019,48(1):77~80. [8] 陈思如.PCT、CRP、hs-CRP在急性轮状病毒肠炎伴心肌损害中的表达[J].现代临床医学,2017,43(3):185~186. [9] 俱永生,王小红.双歧杆菌四联活菌片配合葡萄糖酸锌对小儿轮状病毒性腹泻症状的影响[J].心理医生,2017,23(6):156~157.
2019, Vol. 25 
冀公网安备13080202000677号